Search
for

    Sort by

    Research

    180-210 / 1000+ results
      Acne and Systemic Disease

      research Acne and Systemic Disease

      76 citations , November 2009 in “Medical Clinics of North America”
      This article reviews the hormonal and medication-related factors associated with acne development but does not present new research findings.
      Role of Oxidative Stress in Polycystic Ovary Syndrome

      research Role of Oxidative Stress in Polycystic Ovary Syndrome

      65 citations , May 2010 in “Current Women's Health Reviews”
      This review discusses oxidative stress's role in polycystic ovary syndrome and examines various biomarkers to understand its impact on the disorder's pathogenesis, but reports no new clinical results.
      Changes in the PCOS Phenotype with Age

      research Changes in the PCOS phenotype with age

      62 citations , April 2013 in “Steroids”
      This review discusses the age-related diagnostic challenges and comorbidities of polycystic ovarian syndrome and provides no new clinical findings; the authors emphasize the role of obesity in insulin resistance among affected women.
      Ovarian Hypertension: Polycystic Ovary Syndrome

      research Ovarian Hypertension: Polycystic Ovary Syndrome

      60 citations , May 2011 in “Endocrinology and Metabolism Clinics of North America”
      This article discusses the association between hypertension and polycystic ovary syndrome, highlighting the need for managing related risk factors, but reports no new clinical results.
      Nonclassic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: Pathophysiology, Diagnosis, and Treatment

      research Nonclassic Congenital Adrenal Hyperplasia

      49 citations , January 2010 in “International Journal of Pediatric Endocrinology”
      This review covers the pathophysiology, diagnosis, and treatment of nonclassic congenital adrenal hyperplasia due to P450c21, but it reports no new clinical results.
      Endocrine-Skin Interactions

      research Endocrine-skin interactions

      46 citations , July 1988 in “Journal of The American Academy of Dermatology”
      This review discusses various skin lesions associated with endocrinologic disorders such as Cushing's syndrome and adrenal insufficiency, and it reports no new clinical results.
      Polycystic Ovarian Syndrome: Long-Term Health Consequences

      research Polycystic Ovarian Syndrome: Long-Term Health Consequences

      34 citations , May 2017 in “Seminars in Reproductive Medicine”
      This review discusses the known morbidities of polycystic ovarian syndrome, highlighting its diverse impacts on women's health, but reports no new research findings.
      Alopecia and the Metabolic Syndrome

      research Alopecia and the metabolic syndrome

      30 citations , September 2017 in “Clinics in Dermatology”
      This review explores the relationship between androgenetic alopecia and metabolic syndrome, suggesting an association that supports considering cardiovascular risk assessments in patients with this type of hair loss.
      Nonclassic Congenital Adrenal Hyperplasia: Pathophysiology, Genetics, and Management

      research Nonclassic congenital adrenal hyperplasia

      30 citations , June 2012 in “Current Opinion in Endocrinology, Diabetes and Obesity”
      This review discusses the pathophysiology, genetics, and management of nonclassic congenital adrenal hyperplasia, noting subfertility and hormonal issues without providing new clinical results.
      Venous Thromboembolism and Women's Health

      research Venous thromboembolism and women's health

      22 citations , October 2018 in “British Journal of Haematology”
      This review examines the gender-specific challenges in preventing and treating venous thromboembolism in women and highlights the need for further research on safe and optimal treatment strategies.
      Pharmacologic Treatment of Polycystic Ovary Syndrome

      research Pharmacologic Treatment of Polycystic Ovary Syndrome

      21 citations , January 2003 in “Seminars in reproductive medicine”
      This review outlines the underlying pathophysiology and treatment options for the androgen excess and reproductive and metabolic manifestations of polycystic ovary syndrome, but reports no clinical results.
      The Art of Repair in Surgical Hair Restoration – Part II

      research The Art of Repair in Surgical Hair Restoration–Part II

      17 citations , October 2002 in “Dermatologic Surgery”
      This article provides a guide for surgeons on repairing poorly executed hair transplants, emphasizing meticulous techniques and optimal use of limited hair supply to achieve cosmetic improvements.
      Use of Metformin in Pediatric Age

      research Use of metformin in pediatric age

      16 citations , March 2011 in “Pediatric diabetes”
      Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.
      Approach to Androgen Excess in Women: Clinical and Biochemical Insights

      research Approach to androgen excess in women: Clinical and biochemical insights

      14 citations , March 2022 in “Clinical Endocrinology”
      This review outlines a diagnostic approach for identifying non-PCOS pathology in women with androgen excess, emphasizing the importance of clinical history and biochemical phenotyping but reports no new clinical results.
      Androgen- and Estrogen-Secreting Adrenal Cancers

      research Androgen- and Estrogen-Secreting Adrenal Cancers

      14 citations , December 2010 in “Seminars in Oncology”
      This review discusses the diagnostic challenges of androgen and estrogen-secreting adrenal tumors and highlights that the presence of metastases is the most reliable indicator of malignancy; it reports no new clinical findings.
      The Evaluation and Management of Hirsutism

      research The Evaluation and Management of Hirsutism

      11 citations , May 2003 in “Obstetrics and gynecology (New York. 1953. Online)/Obstetrics and gynecology”
      This review explores the evaluation and treatment of hirsutism, emphasizing a systematic approach to uncovering its causes and recommending combination therapies for effective management, but presents no new results.
      Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review

      research Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review

      9 citations , December 2024 in “Clinical and Experimental Obstetrics & Gynecology”
      This review examines the impact of polycystic ovary syndrome on reproductive health, its pathophysiology, clinical manifestations, and emerging therapies, and reports no new findings; the authors emphasize the need for individualized treatment strategies.
      Hirsuties

      research Hirsuties

      9 citations , March 2001 in “Clinics in dermatology”
      This review examines the causes, assessment, and treatment options for hirsutism but presents no new clinical findings, highlighting the need for further research on managing this condition.
      Obesity, Polycystic Ovarian Syndrome, and Thyroid Dysfunction in Women with Epilepsy

      research Obesity, polycystic ovarian syndrome and thyroid dysfunction in women with epilepsy

      6 citations , January 2012 in “Annals of Indian Academy of Neurology”
      This study found that women with epilepsy on carbamazepine and sodium valproate monotherapy experienced more significant weight gain but showed no difference in PCOS incidence compared to phenytoin users; elevated TSH levels were more common among those on sodium valproate.
      Endocrine Evaluation of Hirsutism

      research Endocrine evaluation of hirsutism

      5 citations , June 2015 in “International Journal of Women's Dermatology”
      This article reviews hirsutism from an endocrine perspective and reports no new clinical findings.
      Pcos And Obesity: Contraception Challenges

      research PCOS and Obesity: Contraception Challenges

      4 citations , May 2025 in “Open Access Journal of Contraception”
      This study suggests that lower-dose ethinyl estradiol formulations and progestin-only contraceptives may offer safer options for managing PCOS in obese women due to minimal metabolic effects.